{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T19:39:07Z","timestamp":1770838747651,"version":"3.50.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2019,1,7]],"date-time":"2019-01-07T00:00:00Z","timestamp":1546819200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1007\/s10620-018-5441-5","type":"journal-article","created":{"date-parts":[[2019,1,8]],"date-time":"2019-01-08T20:00:32Z","timestamp":1546977632000},"page":"1705-1710","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Older Age and Disease Duration Are Highly Associated with Hepatocellular Carcinoma in Patients with Autoimmune Hepatitis"],"prefix":"10.1007","volume":"64","author":[{"given":"Lara","family":"Dakhoul","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keaton R.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samer","family":"Gawrieh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marwan","family":"Ghabril","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chelsey","family":"McShane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raj","family":"Vuppalanchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eduardo","family":"Vilar-Gomez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lauren","family":"Nephew","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naga","family":"Chalasani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Craig","family":"Lammert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,1,7]]},"reference":[{"key":"5441_CR1","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.3109\/00365521.2014.946083","volume":"49","author":"NM Gerven van","year":"2014","unstructured":"van Gerven NM, Verwer BJ, Witte BI, et al. Epidemiology and clinical characteristics of autoimmune hepatitis in the Netherlands. Scand J Gastroenterol. 2014;49:1245\u20131254.","journal-title":"Scand J Gastroenterol"},{"key":"5441_CR2","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1016\/S0140-6736(12)62163-1","volume":"382","author":"MA Heneghan","year":"2013","unstructured":"Heneghan MA, Yeoman AD, Verma S, Smith AD, Longhi MS. Autoimmune hepatitis. Lancet. 2013;382:1433\u20131444.","journal-title":"Lancet"},{"key":"5441_CR3","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1016\/j.jhep.2013.10.020","volume":"60","author":"L Gronbaek","year":"2014","unstructured":"Gronbaek L, Vilstrup H, Jepsen P. Autoimmune hepatitis in Denmark: incidence, prevalence, prognosis, and causes of death. A nationwide registry-based cohort study. J Hepatol. 2014;60:612\u2013617.","journal-title":"J Hepatol"},{"key":"5441_CR4","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1016\/j.cgh.2017.02.006","volume":"15","author":"A Tansel","year":"2017","unstructured":"Tansel A, Katz LH, El-Serag HB, et al. Incidence and determinants of hepatocellular carcinoma in autoimmune hepatitis: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2017;15:1207\u20131217.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"5441_CR5","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/j.jhep.2013.11.025","volume":"60","author":"C Schramm","year":"2014","unstructured":"Schramm C, Lohse AW. Autoimmune hepatitis on the rise. J Hepatol. 2014;60:478\u2013479.","journal-title":"J Hepatol"},{"key":"5441_CR6","doi-asserted-by":"publisher","first-page":"1944","DOI":"10.1111\/j.1572-0241.2008.01922.x","volume":"103","author":"AJ Montano-Loza","year":"2008","unstructured":"Montano-Loza AJ, Carpenter HA, Czaja AJ. Predictive factors for hepatocellular carcinoma in type 1 autoimmune hepatitis. Am J Gastroenterol. 2008;103:1944\u20131951.","journal-title":"Am J Gastroenterol"},{"key":"5441_CR7","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.cgh.2015.07.019","volume":"14","author":"S Mittal","year":"2016","unstructured":"Mittal S, El-Serag HB, Sada YH, et al. Hepatocellular carcinoma in the absence of cirrhosis in United States veterans is associated with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol. 2016;14:124\u2013131.e121.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"5441_CR8","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1053\/j.gastro.2015.08.042","volume":"149","author":"C Lammert","year":"2015","unstructured":"Lammert C, Comerford M, Love J, Bailey JR. Investigation gone viral: application of the social mediasphere in research. Gastroenterology. 2015;149:839\u2013843.","journal-title":"Gastroenterology"},{"key":"5441_CR9","doi-asserted-by":"publisher","first-page":"S-809","DOI":"10.1016\/S0016-5085(10)63729-8","volume":"138","author":"C Macaron","year":"2010","unstructured":"Macaron C, Hanouneh I, Lopez R, Zein NN. S1883 incidence and risk factors of hepatocellular carcinoma in patients with primary biliary cirrhosis and autoimmune hepatitis [Abstract]. Gastroenterology. 2010;138:S-809.","journal-title":"Gastroenterology."},{"key":"5441_CR10","doi-asserted-by":"publisher","first-page":"231","DOI":"10.3748\/wjg.15.231","volume":"15","author":"T Watanabe","year":"2009","unstructured":"Watanabe T, Soga K, Hirono H, et al. Features of hepatocellular carcinoma in cases with autoimmune hepatitis and primary biliary cirrhosis. World J Gastroenterol. 2009;15:231\u2013239.","journal-title":"World J Gastroenterol"},{"key":"5441_CR11","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1007\/s00535-014-0973-8","volume":"50","author":"R Tateishi","year":"2015","unstructured":"Tateishi R, Okanoue T, Fujiwara N, et al. Clinical characteristics, treatment, and prognosis of non-B, non-C hepatocellular carcinoma: a large retrospective multicenter cohort study. J Gastroenterol. 2015;50:350\u2013360.","journal-title":"J Gastroenterol"},{"key":"5441_CR12","doi-asserted-by":"publisher","first-page":"1944","DOI":"10.1023\/A:1005638500236","volume":"45","author":"SZ Park","year":"2000","unstructured":"Park SZ, Nagorney DM, Czaja AJ. Hepatocellular carcinoma in autoimmune hepatitis. Dig Dis Sci. 2000;45:1944\u20131948.","journal-title":"Dig Dis Sci"},{"key":"5441_CR13","doi-asserted-by":"publisher","first-page":"578","DOI":"10.3748\/wjg.15.578","volume":"15","author":"A Teufel","year":"2009","unstructured":"Teufel A, Weinmann A, Centner C, et al. Hepatocellular carcinoma in patients with autoimmune hepatitis. World J Gastroenterol. 2009;15:578\u2013582.","journal-title":"World J Gastroenterol"},{"key":"5441_CR14","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.jhep.2010.01.037","volume":"53","author":"MM Lamers","year":"2010","unstructured":"Lamers MM, van Oijen MG, Pronk M, Drenth JP. Treatment options for autoimmune hepatitis: a systematic review of randomized controlled trials. J Hepatol. 2010;53:191\u2013198.","journal-title":"J Hepatol"},{"key":"5441_CR15","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1097\/MEG.0000000000000527","volume":"28","author":"S Meer van","year":"2016","unstructured":"van Meer S, van Erpecum KJ, Sprengers D, et al. Hepatocellular carcinoma in cirrhotic versus noncirrhotic livers: results from a large cohort in the Netherlands. Eur J Gastroenterol Hepatol. 2016;28:352\u2013359.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"5441_CR16","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.jceh.2013.08.007","volume":"3","author":"A Arora","year":"2013","unstructured":"Arora A, Sharma P, Tyagi P, et al. Hepatitis B virus infection can cause hepatocellular carcinoma in less advanced liver cirrhosis: a comparative study of 142 patients from North India. J Clin Exp Hepatol. 2013;3:288\u2013295.","journal-title":"J Clin Exp Hepatol"},{"key":"5441_CR17","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1111\/jgh.12116","volume":"28","author":"J Alexander","year":"2013","unstructured":"Alexander J, Torbenson M, Wu TT, Yeh MM. Non-alcoholic fatty liver disease contributes to hepatocarcinogenesis in non-cirrhotic liver: a clinical and pathological study. J Gastroenterol Hepatol. 2013;28:848\u2013854.","journal-title":"J Gastroenterol Hepatol"},{"key":"5441_CR18","doi-asserted-by":"publisher","first-page":"3142","DOI":"10.1007\/s10620-015-3821-7","volume":"60","author":"RB Perumpail","year":"2015","unstructured":"Perumpail RB, Wong RJ, Ahmed A, Harrison SA. Hepatocellular carcinoma in the setting of non-cirrhotic nonalcoholic fatty liver disease and the metabolic syndrome: US experience. Dig Dis Sci. 2015;60:3142\u20133148.","journal-title":"Dig Dis Sci"},{"key":"5441_CR19","doi-asserted-by":"publisher","first-page":"S382","DOI":"10.1016\/S0168-8278(13)60929-0","volume":"58","author":"\u00c5 Danielsson Borss\u00e9n","year":"2013","unstructured":"Danielsson Borss\u00e9n \u00c5, Lindgren S, Bergquist A, Almer S, Sangfelt P, Werner M. 927 risk for hepatocellular carcinoma in autoimmune hepatitis\u2014is there an indication for surveillance? [Abstract]. J Hepatol. 2013;58:S382\u2013S383.","journal-title":"J Hepatol"},{"key":"5441_CR20","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1002\/hep.1840080635","volume":"8","author":"KK Wang","year":"1988","unstructured":"Wang KK, Czaja AJ. Hepatocellular carcinoma in corticosteroid-treated severe autoimmune chronic active hepatitis. Hepatology. 1988;8:1679\u20131683.","journal-title":"Hepatology"},{"key":"5441_CR21","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1007\/s10620-010-1444-6","volume":"56","author":"RJ Wong","year":"2011","unstructured":"Wong RJ, Gish R, Frederick T, Bzowej N, Frenette C. Development of hepatocellular carcinoma in autoimmune hepatitis patients: a case series. Dig Dis Sci. 2011;56:578\u2013585.","journal-title":"Dig Dis Sci"},{"key":"5441_CR22","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1111\/j.1365-2036.2006.03104.x","volume":"24","author":"A Floreani","year":"2006","unstructured":"Floreani A, Niro G, Rosa Rizzotto E, et al. Type I autoimmune hepatitis: clinical course and outcome in an Italian multicentre study. Aliment Pharmacol Ther. 2006;24:1051\u20131057.","journal-title":"Aliment Pharmacol Ther"},{"key":"5441_CR23","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1002\/hep.21074","volume":"43","author":"AJ Czaja","year":"2006","unstructured":"Czaja AJ, Carpenter HA. Distinctive clinical phenotype and treatment outcome of type 1 autoimmune hepatitis in the elderly. Hepatology. 2006;43:532\u2013538.","journal-title":"Hepatology"},{"key":"5441_CR24","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1002\/hep.22432","volume":"48","author":"AD Yeoman","year":"2008","unstructured":"Yeoman AD, Al-Chalabi T, Karani JB, et al. Evaluation of risk factors in the development of hepatocellular carcinoma in autoimmune hepatitis: implications for follow-up and screening. Hepatology. 2008;48:863\u2013870.","journal-title":"Hepatology"},{"key":"5441_CR25","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1111\/j.1478-3231.2011.02734.x","volume":"32","author":"K Migita","year":"2012","unstructured":"Migita K, Watanabe Y, Jiuchi Y, et al. Hepatocellular carcinoma and survival in patients with autoimmune hepatitis (Japanese National Hospital Organization-autoimmune hepatitis prospective study). Liver Int. 2012;32:837\u2013844.","journal-title":"Liver Int"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-018-5441-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10620-018-5441-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-018-5441-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,1,7]],"date-time":"2020-01-07T00:17:06Z","timestamp":1578356226000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10620-018-5441-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,7]]},"references-count":25,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["5441"],"URL":"https:\/\/doi.org\/10.1007\/s10620-018-5441-5","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,7]]},"assertion":[{"value":"21 February 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Authors declare no conflicts of interest relevant for this paper.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}